These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Malignant lymphomas in transplantation patients. Penn I; Hammond W; Brettschneider L; Starzl TE Transplant Proc; 1969 Mar; 1(1):106-12. PubMed ID: 4944206 [No Abstract] [Full Text] [Related]
4. Malignant tumours following immunosuppression in renal transplantation. Birkeland SA; Kemp E Proc Eur Dial Transplant Assoc; 1973; 10(0):429-33. PubMed ID: 4370181 [No Abstract] [Full Text] [Related]
5. [Malignant tumors following transplantation. Case reports and review of the literature]. Guisan Y; Enderlin F; Harder F; Brunner F; Thiel G; Bernhardt JP; Schädeli J; Mihatsch M Schweiz Med Wochenschr; 1973 Apr; 103(16):577-85. PubMed ID: 4610738 [No Abstract] [Full Text] [Related]
6. [Results and problems of kidney transplantation]. Wolff HP Dtsch Med Wochenschr; 1966 Apr; 91(16):738-43. PubMed ID: 4160147 [No Abstract] [Full Text] [Related]
7. Tissue immunity and organ transplantation. Russell PS Surg Gynecol Obstet; 1968 Jun; 126(6):1203-15. PubMed ID: 4172388 [No Abstract] [Full Text] [Related]
8. Renal allograft rejection in man. A study of 35 transplantations from living donors. Pasternack A; Kuhlbäck B; Koivunen O; Lindström B; Tiilikainen A Scand J Urol Nephrol; 1970; 4(3):238-43. PubMed ID: 4103331 [No Abstract] [Full Text] [Related]
9. [Malignant tumors under immunosuppression, a new problem in transplant-recipients]. Enderlin F; Guisan Y Helv Chir Acta; 1973 Dec; 40(5):773-6. PubMed ID: 4589045 [No Abstract] [Full Text] [Related]
11. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Penn I; Starzl TE Transplantation; 1972 Oct; 14(4):407-17. PubMed ID: 4345337 [TBL] [Abstract][Full Text] [Related]
12. De-novo brain tumours in renal-transplant recipients. Schneck SA; Penn I Lancet; 1971 May; 1(7707):983-6. PubMed ID: 4102451 [No Abstract] [Full Text] [Related]
13. Successful treatment of acute cardiac homograft rejection without antilymphocyte globulin. Kauffman HM; Lepley D; Johnson D; Kuban D Laval Med; 1970 Feb; 41(2):260-1. PubMed ID: 4102120 [No Abstract] [Full Text] [Related]
14. Results of the kidney transplantation in the Warsaw Center. Nielubowicz J; Orlowski T; Wesolowski S; Falda Z; Gradowska L; Rowińska D; Rowiński W; Skośkiewicz M; Szostek M; Filipowicz Z; Glyda J; Goliszek Z; Jedrzejewski R; Kardasiewicz W; Klepacka J; Klopotowska E; Kossowska B; Koziak H; Krzywicka E; Lao M; Ladygin J; Marzinek B; Miller J; Michalowicz B; Machowski Z; Olszewski K Pol Med J; 1971; 10(2):340-3. PubMed ID: 4104328 [No Abstract] [Full Text] [Related]
15. Further observations on renal transplants in man from cadaveric donors. Calne RY; Loughridge L; MacGillivray JB; Swales JD Br Med J; 1966 Dec; 2(5526):1345-51. PubMed ID: 4163407 [No Abstract] [Full Text] [Related]
16. The influence of histocompatibility on graft and patient survival in primary cadaver kidney transplantation. Storm B; Lindholm A Proc Eur Dial Transplant Assoc; 1972; 9():466-74. PubMed ID: 4589765 [No Abstract] [Full Text] [Related]
17. Methods to prevent rejection of homografts in man: a report on living related kidney donor selection by HL-A genotyping. Stickel DL; Seigler HF; Ward FE Am Surg; 1970 Feb; 36(2):109-15. PubMed ID: 4904925 [No Abstract] [Full Text] [Related]